Page last updated: 2024-10-25

dapsone and Apoplexy

dapsone has been researched along with Apoplexy in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Dapsone appears as a useful and safe drug for the treatment of stroke patients."9.12Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study. ( Calzada, P; Góngora-Rivera, F; Nader-Kawachi, J; Ríos, C; Santos-Zambrano, J, 2007)
" We have shown that dapsone acts as an antioxidant, antiinflammatory and antiapoptotic agent after brain Ischemia reperfusion (I/R) in rats; however, its therapeutic efficacy, measured by imaging has not been characterized."7.83Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. ( Diaz-Ruiz, A; Heras-Romero, Y; Mendez-Armenta, M; Mondragón-Lozano, R; Nava-Ruiz, C; Ortiz-Plata, A; Osorio-Rico, L; Ríos, C; Roldan-Valadez, E, 2016)
"Dapsone appears as a useful and safe drug for the treatment of stroke patients."5.12Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study. ( Calzada, P; Góngora-Rivera, F; Nader-Kawachi, J; Ríos, C; Santos-Zambrano, J, 2007)
" We have shown that dapsone acts as an antioxidant, antiinflammatory and antiapoptotic agent after brain Ischemia reperfusion (I/R) in rats; however, its therapeutic efficacy, measured by imaging has not been characterized."3.83Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. ( Diaz-Ruiz, A; Heras-Romero, Y; Mendez-Armenta, M; Mondragón-Lozano, R; Nava-Ruiz, C; Ortiz-Plata, A; Osorio-Rico, L; Ríos, C; Roldan-Valadez, E, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diaz-Ruiz, A1
Roldan-Valadez, E1
Ortiz-Plata, A1
Mondragón-Lozano, R1
Heras-Romero, Y1
Mendez-Armenta, M1
Osorio-Rico, L1
Nava-Ruiz, C1
Ríos, C2
Nader-Kawachi, J1
Góngora-Rivera, F1
Santos-Zambrano, J1
Calzada, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke[NCT01144650]Phase 2/Phase 3300 participants (Anticipated)Interventional2009-07-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for dapsone and Apoplexy

ArticleYear
Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
    Neurological research, 2007, Volume: 29, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Dapsone; Dose-Response Relationship, Drug; Double-Blind Method; Fema

2007

Other Studies

1 other study available for dapsone and Apoplexy

ArticleYear
Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats.
    Brain research, 2016, 09-01, Volume: 1646

    Topics: Animals; Brain; Brain Ischemia; Dapsone; Magnetic Resonance Imaging; Male; Neuroprotective Agents; N

2016
chemdatabank.com